|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
3
|
Donato F, Boffetta P and Puoti M: A
meta-analysis of epidemiological studies on the combined effect of
hepatitis B and C virus infections in causing hepatocellular
carcinoma. Int J Cancer. 75:347–354. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seitz HK and Stickel F: Risk factors and
mechanisms of hepatocarcinogenesis with special emphasis on alcohol
and oxidative stress. Biol Chem. 387:349–360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Severi T, Ying C, Vermeesch JR, Cassiman
D, Cnops L, Verslype C, Fevery J, Arckens L, Neyts J and van Pelt
JF: Hepatitis B virus replication causes oxidative stress in
HepAD38 liver cells. Mol Cell Biochem. 290:79–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsieh YH, Su IJ, Wang HC, Chang WW, Lei
HY, Lai MD, Chang WT and Huang W: Pre-S mutant surface antigens in
chronic hepatitis B virus infection induce oxidative stress and DNA
damage. Carcinogenesis. 25:2023–2032. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qadri I, Iwahashi M, Capasso JM, Hopken
MW, Flores S, Schaack J and Simon FR: Induced oxidative stress and
activated expression of manganese superoxide dismutase during
hepatitis C virus replication: role of JNK, p38 MAPK and AP-1.
Biochem J. 378:919–928. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moriya K, Nakagawa K, Santa T, Shintani Y,
Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T,
Imai K, Todoroki T, Kimura S and Koike K: Oxidative stress in the
absence of inflammation in a mouse model for hepatitis C
virus-associated hepatocarcinogenesis. Cancer Res. 61:4365–4370.
2001.PubMed/NCBI
|
|
9
|
Wang Y, Millonig G, Nair J, Patsenker E,
Stickel F, Mueller S, Bartsch H and Seitz HK: Ethanol-induced
cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in
alcoholic liver disease. Hepatology. 50:453–461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu HC, Wang Q, Wang LW, Yang HI, Ahsan H,
Tsai WY, Wang LY, Chen SY, Chen CJ and Santella RM: Urinary
8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus
infection and hepatocellular carcinoma in Taiwan. Carcinogenesis.
28:995–999. 2007.PubMed/NCBI
|
|
11
|
Starley BQ, Calcagno CJ and Harrison SA:
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a
weighty connection. Hepatology. 51:1820–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Toyokuni S, Okamoto K, Yodoi J and Hiai H:
Persistent oxidative stress in cancer. FEBS Lett. 358:1–3. 1995.
View Article : Google Scholar
|
|
13
|
Bartsch H and Nair J: Chronic inflammation
and oxidative stress in the genesis and perpetuation of cancer:
role of lipid peroxidation, DNA damage, and repair. Langenbecks
Arch Surg. 391:499–510. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
el Ghissassi F, Barbin A, Nair J and
Bartsch H: Formation of 1,
N6-ethenoadenine and 3,
N4-ethenocytosine by lipid peroxidation
products and nucleic acid bases. Chem Res Toxicol. 8:278–283.
1995.
|
|
15
|
Barbin A, Froment O, Boivin S, Marion MJ,
Belpoggi F, Maltoni C and Montesano R: p53 gene mutation pattern in
rat liver tumors induced by vinyl chloride. Cancer Res.
57:1695–1698. 1997.PubMed/NCBI
|
|
16
|
Horio Y, Chen A, Rice P, Roth JA,
Malkinson AM and Schrump DS: Ki-ras and p53 mutations are early and
late events, respectively, in urethane-induced pulmonary
carcinogenesis in A/J mice. Mol Carcinog. 17:217–223. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nair J, Carmichael PL, Fernando RC,
Phillips DH, Strain AJ and Bartsch H: Lipid peroxidation-induced
etheno-DNA adducts in the liver of patients with the genetic metal
storage disorders Wilson’s disease and primary hemochromatosis.
Cancer Epidemiol Biomarkers Prev. 7:435–440. 1998.PubMed/NCBI
|
|
18
|
Frank A, Seitz HK, Bartsch H, Frank N and
Nair J: Immunohistochemical detection of 1,
N6-ethenodeoxyadenosine in nuclei of human
liver affected by diseases predisposing to hepatocarcinogenesis.
Carcinogenesis. 25:1027–1031. 2004.
|
|
19
|
Nair J, Srivatanakul P, Haas C,
Jedpiyawongse A, Khuhaprema T, Seitz HK and Bartsch H: High urinary
excretion of lipid peroxidation-derived DNA damage in patients with
cancer-prone liver diseases. Mutat Res. 683:23–28. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Desmet VJ, Gerber M, Hoofnagle JH, Manns M
and Scheuer PJ: Classification of chronic hepatitis: diagnosis,
grading and staging. Hepatology. 19:1513–1520. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ichiba M, Maeta Y, Mukoyama T, Saeki T,
Yasui S, Kanbe T, Okano J, Tanabe Y, Hirooka Y, Yamada S, Kurimasa
A, Murawaki Y and Shiota G: Expression of
8-hydroxy-2′-deoxyguanosine in chronic liver disease and
hepatocellular carcinoma. Liver Int. 23:338–345. 2003.
|
|
22
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: a radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bossi G, Lapi E, Strano S, Rinaldo C,
Blandino G and Sacchi A: Mutant p53 gain of function: reduction of
tumor malignancy of human cancer cell lines through abrogation of
mutant p53 expression. Oncogene. 25:304–309. 2006.PubMed/NCBI
|
|
24
|
Shaulsky G, Goldfinger N and Rotter V:
Alterations in tumor development in vivo mediated by expression of
wild type or mutant p53 proteins. Cancer Res. 51:5232–5237.
1991.PubMed/NCBI
|
|
25
|
Kitada T, Seki S, Iwai S, Yamada T,
Sakaguchi H and Wakasa K: In situ detection of oxidative DNA
damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J
Hepatol. 35:613–618. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar
|
|
27
|
Novo E and Parola M: Redox mechanisms in
hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue
Repair. 1:52008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bataller R, Schwabe RF, Choi YH, Yang L,
Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters
JJ and Brenner DA: NADPH oxidase signal transduces angiotensin II
in hepatic stellate cells and is critical in hepatic fibrosis. J
Clin Invest. 112:1383–1394. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bartsch H, Barbin A, Marion MJ, Nair J and
Guichard Y: Formation, detection, and role in carcinogenesis of
ethenobases in DNA. Drug Metab Rev. 26:349–371. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Basu AK, Wood ML, Niedernhofer LJ, Ramos
LA and Essigmann JM: Mutagenic and genotoxic effects of three vinyl
chloride-induced DNA lesions: 1,
N6-ethenoadenine, 3,
N4-ethenocytosine, and
4-amino-5-(imidazol-2-yl)imidazole. Biochemistry. 32:12793–12801.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pandya GA and Moriya M: 1,
N6-ethenodeoxyadenosine, a DNA adduct
highly mutagenic in mammalian cells. Biochemistry. 35:11487–11492.
1996.
|
|
32
|
Palejwala VA, Rzepka RW, Simha D and
Humayun MZ: Quantitative multiplex sequence analysis of mutational
hot spots. Frequency and specificity of mutations induced by a
site-specific ethenocytosine in M13 viral DNA. Biochemistry.
32:4105–4111. 1993. View Article : Google Scholar
|
|
33
|
Moriya M, Zhang W, Johnson F and Grollman
AP: Mutagenic potency of exocyclic DNA adducts: marked differences
between Escherichia coli and simian kidney cells. Proc Natl
Acad Sci USA. 91:11899–11903. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng KC, Preston BD, Cahill DS, Dosanjh
MK, Singer B and Loeb LA: The vinyl chloride DNA derivative
N2, 3-ethenoguanine produces G→A
transitions in Escherichia coli. Proc Natl Acad Sci USA.
88:9974–9978. 1991.PubMed/NCBI
|
|
35
|
Barbin A, Bartsch H, Leconte P and Radman
M: Studies on the miscoding properties 1,
N6-ethenoadenine and 3,
N4-ethenocytosine, DNA reaction products
of vinyl chloride metabolites, during in vitro DNA synthesis.
Nucleic Acids Res. 9:375–387. 1981.
|
|
36
|
Miller JA and Miller EC: The metabolic
activation and nucleic acid adducts of naturally-occurring
carcinogens: recent results with ethyl carbamate and the spice
flavors safrole and estragole. Br J Cancer. 48:1–15. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Levine RL, Yang IY, Hossain M, Pandya GA,
Grollman AP and Moriya M: Muta-genesis induced by a single 1,
N6-ethenodeoxyadenosine adduct in human
cells. Cancer Res. 60:4098–4104. 2000.PubMed/NCBI
|
